Promoting development in emerging economies
Regenerative medicine is usually considered high-tech and expensive - more suitable for the developed world. But the ability to repair or regenerate tissue may be of even greater benefit in the developing world, where the incidence of diseases such as diabetes or heart disease and accidents and burns is greater than in the developed world.
Dr. Daar's research team includes lawyers, ethicists, philosophers, social scientists and biomedical researchers from across Canada and the United States. They recently completed a study of the most promising applications for regenerative medicine in the developing world. Dr. Daar and his colleagues found that strategies for pancreatic islet regeneration, cardiac cell regeneration, and engineered immune cells would prove the most beneficial for easing the burden of chronic disease in developing countries. The study follows on the heels of a similar investigation of the top nanotechnologies for addressing urgent global health needs.
Dr. Daar's team is now looking at how low-to-middle income countries are using regenerative medicine. In a recent article, they documented regenerative medicine innovations in India. The team has also completed a similar study in China and has another underway in Brazil. Additionally, they are investigating the challenges associated with the application of neuro-regenerative medicine, with a focus on understanding these technologies in emerging economies.
Supplemental content (right column)